Literature DB >> 8183779

Graves' disease mimicking beta-thalassemia trait.

M S Akasheh1.   

Abstract

A case of Graves' disease associated with splenomegaly, lymphadenopathy, microcytic hypochromic anaemia, and a raised haemoglobin A2 is presented. The haematological indices returned to normal after conventional treatment with anti-thyroid medication.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8183779      PMCID： PMC2397873          DOI： 10.1136/pgmj.70.822.300

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

Review 1.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

2.  Erythropoiesis and erythropoietin in hypo- and hyperthyroidism.

Authors:  K C Das; M Mukherjee; T K Sarkar; R J Dash; G K Rastogi
Journal:  J Clin Endocrinol Metab       Date:  1975-02       Impact factor: 5.958

3.  The haematology of hyperthyroidism.

Authors:  S Nightingale; P J Vitek; R L Himsworth
Journal:  Q J Med       Date:  1978-01

4.  Hemoglobin A2 in hyperthyroidism.

Authors:  A G Kendall; C H Bastomsky
Journal:  Hemoglobin       Date:  1981       Impact factor: 0.849

5.  Influence of thyroid status on hemoglobin A2 expression.

Authors:  J M Kuhn; M Rieu; J Rochette; R Krishnamoorthy; D Labie; J Elion; J P Luton; H Bricaire
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958
  5 in total
  2 in total

1.  Juvenile Graves' disease with opthalmopathy, lymphadenopathy, accelerated growth and congestive cardiac failure.

Authors:  M K Dutta; Abhay Gundgurthi; M K Garg; N Kotwal
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

2.  Atypical clinical manifestations of graves' disease: an analysis in depth.

Authors:  Mohamed Osama Hegazi; Sherif Ahmed
Journal:  J Thyroid Res       Date:  2011-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.